This study was an attempt at developing, establishing, validating and comparing the modified PAP method for detection of hetero-vancomycin resistant Staphylococcus aureus (h-VRSA) with the routine antimicrobial susceptibility testing (using the BSAC standardized disc diffusion method), minimum inhibitory concentrations of vancomycin using standard E-test methodology and the Hiramatsu′s screening method. A total of 50 methicillin resistant Staphylococcus aureus obtained from various clinical specimens, along with the Mu 3 and Mu 50 strains as controls, were studied. No VRSA isolates were obtained. However, four of the test strains were positive by the Hiramatsu′s screening method, of which only one isolate could be confirmed by the modifi...
The emergence of Staphylococcus aureus strains with intermediate resistance (VISA) and heterogen res...
Backgrounds: To determine the true incidence of hGISA/GISA and its consequent clinical impact, metho...
Vancomycin has been the primary agent used to treat serious Methicillin-resistant Staphylococcus aur...
This study was an attempt at developing, establishing, validating and comparing the modified PAP met...
The best screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureu...
INTRODUCTION: Staphylococcus aureus plays an important role in cause of many infections. Methicill...
The objective of this study was to investigate screening methodologies, to detect Staphylococcus au...
Background and Aim: Vancomycin is one of the last drugs used by human for treatment of infections ca...
PubMed ID: 18173069The emergence of Staphylococcus aureus strains with intermediate resistance (VISA...
WOS: 000251478700003PubMed ID: 18173069The emergence of Staphylococcus aureus strains with intermedi...
Vancomycin resistance in Staphylococcus aureus has emerged over the last ten years due to varying me...
Incidence of vancomycin intermediate Staphylococcus aureus (VISA) and vancomycin hetero-intermediate...
This study analyzed clinical and microbiological characteristics of heteroresistant (hVISA) and vanc...
International audienceThe study presented here was performed to evaluate the ability of various nona...
AbstractVancomycin resistance in Staphylococcus aureus has emerged over the last ten years due to va...
The emergence of Staphylococcus aureus strains with intermediate resistance (VISA) and heterogen res...
Backgrounds: To determine the true incidence of hGISA/GISA and its consequent clinical impact, metho...
Vancomycin has been the primary agent used to treat serious Methicillin-resistant Staphylococcus aur...
This study was an attempt at developing, establishing, validating and comparing the modified PAP met...
The best screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureu...
INTRODUCTION: Staphylococcus aureus plays an important role in cause of many infections. Methicill...
The objective of this study was to investigate screening methodologies, to detect Staphylococcus au...
Background and Aim: Vancomycin is one of the last drugs used by human for treatment of infections ca...
PubMed ID: 18173069The emergence of Staphylococcus aureus strains with intermediate resistance (VISA...
WOS: 000251478700003PubMed ID: 18173069The emergence of Staphylococcus aureus strains with intermedi...
Vancomycin resistance in Staphylococcus aureus has emerged over the last ten years due to varying me...
Incidence of vancomycin intermediate Staphylococcus aureus (VISA) and vancomycin hetero-intermediate...
This study analyzed clinical and microbiological characteristics of heteroresistant (hVISA) and vanc...
International audienceThe study presented here was performed to evaluate the ability of various nona...
AbstractVancomycin resistance in Staphylococcus aureus has emerged over the last ten years due to va...
The emergence of Staphylococcus aureus strains with intermediate resistance (VISA) and heterogen res...
Backgrounds: To determine the true incidence of hGISA/GISA and its consequent clinical impact, metho...
Vancomycin has been the primary agent used to treat serious Methicillin-resistant Staphylococcus aur...